NO20025152D0 - EDG8-reseptor, dens fremstilling og anvendelse - Google Patents

EDG8-reseptor, dens fremstilling og anvendelse

Info

Publication number
NO20025152D0
NO20025152D0 NO20025152A NO20025152A NO20025152D0 NO 20025152 D0 NO20025152 D0 NO 20025152D0 NO 20025152 A NO20025152 A NO 20025152A NO 20025152 A NO20025152 A NO 20025152A NO 20025152 D0 NO20025152 D0 NO 20025152D0
Authority
NO
Norway
Prior art keywords
preparation
receptor
polynucleotides
edg8
edg8 receptor
Prior art date
Application number
NO20025152A
Other languages
English (en)
Other versions
NO331197B1 (no
NO20025152L (no
Inventor
Evi Kostenis
Johann Gassenhuber
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP00108858A external-priority patent/EP1149907A1/en
Priority claimed from EP00116589A external-priority patent/EP1178110A1/en
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Publication of NO20025152D0 publication Critical patent/NO20025152D0/no
Publication of NO20025152L publication Critical patent/NO20025152L/no
Publication of NO331197B1 publication Critical patent/NO331197B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Neurology (AREA)
  • Physics & Mathematics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Hematology (AREA)
  • Neurosurgery (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Diabetes (AREA)
NO20025152A 2000-04-26 2002-10-25 Fremgangsmate for a identifisere forbindelser som binder til EDG8-polypeptid NO331197B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP00108858A EP1149907A1 (en) 2000-04-26 2000-04-26 EDG8 receptor, its preparation and use
EP00116589A EP1178110A1 (en) 2000-08-01 2000-08-01 EDG8 receptor for sphingosine 1-phosphate , its preparation and use
PCT/EP2001/004283 WO2001081573A1 (en) 2000-04-26 2001-04-14 Edg8 receptor, its preparation and use

Publications (3)

Publication Number Publication Date
NO20025152D0 true NO20025152D0 (no) 2002-10-25
NO20025152L NO20025152L (no) 2002-12-13
NO331197B1 NO331197B1 (no) 2011-10-31

Family

ID=26070860

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20025152A NO331197B1 (no) 2000-04-26 2002-10-25 Fremgangsmate for a identifisere forbindelser som binder til EDG8-polypeptid

Country Status (14)

Country Link
US (2) US20020099191A1 (no)
EP (1) EP1278850B1 (no)
JP (1) JP5139617B2 (no)
KR (1) KR100790329B1 (no)
AT (1) ATE364697T1 (no)
AU (2) AU7048901A (no)
BR (1) BR0110248A (no)
CA (1) CA2406725C (no)
DE (1) DE60128906T2 (no)
IL (2) IL152378A0 (no)
MX (1) MXPA02010241A (no)
NO (1) NO331197B1 (no)
NZ (1) NZ522215A (no)
WO (1) WO2001081573A1 (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6812335B1 (en) 1999-03-23 2004-11-02 The Regents Of The University Of California Human polypeptide receptors for lysophospholipids and sphingolipids and nucleic acids encoding the same
US20040185535A1 (en) * 2003-03-21 2004-09-23 Giles Wilson Industrial-scale serum-free production of recombinant FVII in mammalian cells
DE60141908D1 (de) * 2000-10-02 2010-06-02 Novo Nordisk Healthcare Ag Glykoformen von faktor vii
US20040185534A1 (en) * 2000-10-02 2004-09-23 Knudsen Ida Molgaard Industrial-scale serum-free production of recombinant proteins in mammalian cells
EP1448583A4 (en) * 2001-07-20 2006-02-08 Aventis Pharma Inc NEW G PROTEIN COUPLED RECEPTOR, GAVE8
EP1597580A2 (en) * 2002-11-13 2005-11-23 Bayer HealthCare AG Diagnostics and therapeutics for diseases associated with human endothelial differentiation, sphingolipid g-protein-coupled receptor 5 (edg5)
WO2005009469A1 (ja) * 2003-07-28 2005-02-03 Sumitomo Pharmaceuticals Co., Ltd. 新規血糖調節薬及びそのスクリーニング方法
US20090191578A1 (en) * 2004-07-27 2009-07-30 Merck & Co., Inc Canis sphingosine 1-phosphate receptor isoform 5
US8791100B2 (en) 2010-02-02 2014-07-29 Novartis Ag Aryl benzylamine compounds
WO2014139884A2 (en) 2013-03-14 2014-09-18 Galapagos Nv Molecular targets and compounds, and methods to identify the same, useful in the treatment of fibrosis

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6555339B1 (en) * 1997-04-14 2003-04-29 Arena Pharmaceuticals, Inc. Non-endogenous, constitutively activated human protein-coupled receptors
WO1999019513A2 (en) * 1997-10-10 1999-04-22 Lxr Biotechnology, Inc. Methods for detecting compounds which modulate the activity of an lpa receptor
CA2340334A1 (en) * 1998-08-19 2000-03-02 Millenium Pharmaceuticals, Inc. 14274 receptor, a g-protein coupled receptor related to the edg receptor family
WO2001004139A2 (en) * 1999-07-13 2001-01-18 Smithkline Beecham Corporation Human axor29 receptor
GB9923890D0 (en) * 1999-10-08 1999-12-08 Pfizer Ltd Novel polypeptide

Also Published As

Publication number Publication date
CA2406725A1 (en) 2001-11-01
JP2003530882A (ja) 2003-10-21
KR20020097234A (ko) 2002-12-31
NO331197B1 (no) 2011-10-31
KR100790329B1 (ko) 2008-01-02
NO20025152L (no) 2002-12-13
EP1278850A1 (en) 2003-01-29
IL152378A (en) 2010-12-30
US20030219874A1 (en) 2003-11-27
EP1278850B1 (en) 2007-06-13
IL152378A0 (en) 2003-05-29
DE60128906T2 (de) 2008-02-07
NZ522215A (en) 2004-05-28
JP5139617B2 (ja) 2013-02-06
AU2001270489B2 (en) 2007-03-15
DE60128906D1 (de) 2007-07-26
ATE364697T1 (de) 2007-07-15
US7141383B2 (en) 2006-11-28
WO2001081573A1 (en) 2001-11-01
BR0110248A (pt) 2003-01-07
MXPA02010241A (es) 2004-09-06
CA2406725C (en) 2013-01-15
AU7048901A (en) 2001-11-07
US20020099191A1 (en) 2002-07-25

Similar Documents

Publication Publication Date Title
EA200300441A1 (ru) Ассоциация антагониста рецептора св1 и сибутрамина, содержащие их фармацевтические композиции и их применение для лечения ожирения
YU19903A (sh) Novi receptor nukleinskih kiselina i polipeptida
ITUD20030092A1 (it) Protesi per l'articolazione della spalla.
TW200631594A (en) Toll like receptor 3 antagonists, methods and uses
BG108495A (en) 5-ht receptor ligands and uses thereof
ATE439166T1 (de) Hemmung von il-17 produktion
NO20033285L (no) FLT4(VEGFR-3) som et mål for tumoravbildning og anti-tumor terapi
IS7815A (is) 3-Fenýl setið pýridóindólón, framleiðsla og meðferðarleg notkun þess.
ATE419845T1 (de) Il-8-rezeptor-antagonisten
NO20025152L (no) EDG8-reseptor, dens fremstilling og anvendelse
MXPA03002971A (es) Receptores de hematopoyetina hpr1 y hpr2.
ATE363531T1 (de) Claudin polypeptide
NO20040499L (no) Substituerte pyridin-4-oner og deres andvendelse som gonadotropin-frigjorende hormon reseptor antagonister.
WO2003002604A3 (en) G protein coupled receptors and dna sequences thereof
EA200601220A1 (ru) Анти-trkc антитела-агонисты и способы их применения
WO2003018798A3 (en) G-protein coupled receptor and dna sequences thereof
WO2002002630A3 (en) Hcn polypeptides and polynucleotides and their use in therapy
ATE464893T1 (de) N,n'-diarylguanidine als il-8-rezeptor- antagonisten
TR200103448T2 (tr) IL-8 reseptör antagonistleri.
WO2005046602A3 (en) Vegf receptor antagonists
WO2003018066A3 (en) A murine genomic polynucleotide sequence encoding a g-protein coupled receptor and methods of use therefor
ZA200205477B (en) 5HT3 receptors of nematodes, polynucleotide molecules encoding same, and antagonists thereof.
DK1420789T3 (da) Anvendelse af aktivstoffer med my-opioid-receptoragonistisk virkning og opioid-receptorantagonistisk virkning som kombinationslægemidler til cancerbehandling
DE60130686D1 (de) Funktionelles fragment des leptinrezeptors
AU2003234717A8 (en) Novel polynucleotides encoding the human citron kinase polypeptide, bmsnkc 0020/0021

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees